These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 10440909

  • 1. Changes of plasma hemostatic markers during percutaneous transluminal coronary angioplasty in patients with chronic coronary artery disease.
    Saito Y, Wada H, Yamamuro M, Inoue A, Shimura M, Hiyoyama K, Gabazza EC, Isaka N, Shiku H, Takeya H, Suzuki K, Kumeda K, Kato H, Nakano T.
    Am J Hematol; 1999 Aug; 61(4):238-42. PubMed ID: 10440909
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tissue factor expression in coronary circulation as a prognostic factor for late restenosis after coronary angioplasty.
    Mizuno O, Ikeda U, Hojo Y, Fujikawa H, Katsuki T, Shimada K.
    Cardiology; 2001 Aug; 95(2):84-9. PubMed ID: 11423712
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Decreased protein C inhibitor after percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction.
    Tanigawa M, Wada H, Minamikawa K, Wakita Y, Nagaya S, Mori T, Tamaki S, Nishikawa H, Kakuta Y, Nakano T.
    Am J Hematol; 1995 May; 49(1):1-5. PubMed ID: 7741129
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antithrombin III supplementation for patients undergoing PTCA for unstable angina pectoris. A controlled randomized double-blind pilot study.
    Grip L, Blombäck M, Egberg N, Olsson A, Svane B, Velander M.
    Eur Heart J; 1997 Mar; 18(3):443-9. PubMed ID: 9076381
    [Abstract] [Full Text] [Related]

  • 15. Activation of the immune system and coronary artery disease: the role of anti-endothelial cell antibodies.
    Farsi A, Domeneghetti MP, Brunelli T, Gori AM, Fedi S, Gensini GF, Giglioli C, Prisco D, Passaleva A, Meroni PL, Del Papa N, Abbate R.
    Atherosclerosis; 2001 Feb 01; 154(2):429-36. PubMed ID: 11166776
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hemostatic and fibrinolytic parameters in survivors of myocardial infarction: a low plasma level of plasmin-alpha2-antiplasmin complex is an independent predictor of coronary re-events.
    Redondo M, Carroll VA, Mauron T, Biasiutti FD, Binder BR, Lämmle B, Wuillemin WA.
    Blood Coagul Fibrinolysis; 2001 Jan 01; 12(1):17-24. PubMed ID: 11229822
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.